Effect of 5-campestenone (24-methylcholest-5-en-3-one) on Zucker diabetic fatty rats as a type 2 diabetes mellitus model

Hormone and Metabolic Research

Volumn 37, Issue 2, 2005, Pages 79-83

  Konno, R ^a   Kaneko, Y ^a   Suzuki, K ^a   Matsui, Y ^b  

^a RIKEN   (Japan)

^b Ninon Bioresearch Inc   (Japan)

Author keywords

5 campestenone; Body fat (adipose tissue); Plasma non esterified fatty acid; Plasma triglyceride; Zucker diabetic fatty rat

Indexed keywords

5 CAMPESTENONE; CHOLESTANE DERIVATIVE; CHOLESTEROL; FATTY ACID; HEMOGLOBIN A1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DRUG EFFECT; EPIDIDYMIS; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; RAT STRAIN; RETROPERITONEUM; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CHOLESTENONES; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A; LEPTIN; LIPIDS; RATS; RATS, ZUCKER;

ANIMALIA;

EID: 15944396526     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861171     Document Type: Article

References (12)

1. Lee Y, Hirose H, Ohneda M, Johnson JH, MacGarry JD. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell-relationships. Proc Natl Acad Sci USA 1994; 91: 10878-10882
2. Randle PJ, Arland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789
3. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10
4. Suzuki K. Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol, on mice. J Nutr Sci Vitaminol 1993; 39: 537-543
5. Suzuki K, Shimizu T, Nakata T. The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice. Bioorg Med Chem Lett 1998; 8: 2133-2138
6. Suzuki K, Tanaka M, Konno R, Kaneko Y. Effect of 5-Campestenone (24-Methylcholest-5-en-3-one) on the Type 2 Diabetes Mellitus Model Animal C57BL/Ksj-db/db Mice. Horm Metab Res 2002; 34: 121-126
7. Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakano K. Molecular cloning of rat leptin receptor isoform complementary DNAs: identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 1996; 5, 225 (1): 75-83
8. Parish EJ, Luo C, Parish S, Heideprien RW. Selective oxidation of steroidal homoallylic alcohols using pyridium chlorochromate (PPC). Synthetic Communications 1992; 22: 2839-2847
9. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36 (1): 54-59
10. Norman M, Kaplan MD. Deadly Quartet. Arch Intern Med 1989; 149: 1514-1520
11. Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arznein-Forsch/Drug. Res 1990; 40 (1): 156-162
12. Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arznein-Forsch/Drug Res 1990; 40 (1): 263-267